Table 1.
Baseline demographic and medical characteristics for all participants, and by post-treatment remission status (HAM-D≤7)
| Characteristics | ||||
|---|---|---|---|---|
| All participants (N=157) |
Nonremitters (N=76) |
Remitters (N=81) |
P | |
| Demographics | ||||
| Age (in years) | 59.9 ± 8.7 | 59.6 ± 9.2 | 60.2 ± 8.2 | .68 |
| Gender (female) | 62 (39.5) | 32 (42.1) | 30 (37.0) | .52 |
| Race (Caucasian) | 129 (82.2) | 60 (79.0) | 69 (85.2) | .31 |
| Education (12+ years) | 146 (93.0) | 70 (92.1) | 76 (93.8) | .67 |
| Medical | ||||
| History of MI | 98 (62.4) | 43 (56.6) | 55 (67.9) | .14 |
| History of CHF | 35 (22.3) | 20 (26.3) | 15 (18.5) | .24 |
| Diabetes | 68 (43.3) | 37 (48.7) | 31 (38.3) | .19 |
| Hypertension | 129 (82.2) | 64 (84.2) | 65 (80.3) | .52 |
| History of CABG | 56 (35.7) | 30 (39.5) | 26 (32.1) | .34 |
| History of PTCA | 117 (74.5) | 55 (73.3) | 62 (76.5) | .64 |
| Body Mass Index (kg/m2) | 31.7 ± 6.2 | 31.1 ± 5.3 | 32.1 ± 6.9 | .31 |
| Current Smoker | 38 (24.2) | 18 (23.7) | 20 (24.7) | .88 |
| Medications | ||||
| Statin | 134 (85.4) | 63 (82.9) | 71 (87.7) | .40 |
| Nitrate | 37 (23.6) | 15 (19.7) | 22 (27.2) | .27 |
| Beta blocker | 129 (82.2) | 59 (77.6) | 70 (86.4) | .15 |
| Aspirin | 146 (93.0) | 71 (93.4) | 75 (92.6) | .84 |
| Insulin | 35 (22.3) | 21 (27.6) | 14 (17.3) | .12 |
| Anxiolytic | 45 (28.7) | 22 (29.0) | 23 (28.4) | .94 |
| Antidepressant | 77 (49.0) | 41 (54.0) | 36 (44.4) | .23 |
*
Continuous variables are reported as mean ± SD. Categorical variables reported as number and (%) of participants. One way ANOVA and chi-square tests were used to compare groups.